首页 › 前列腺癌 › 哥伦比亚特区 › Washington
Washington DC 前列腺癌临床试验
38项针对 前列腺癌的研究正在 Washington及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation Therapy
招募中2 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
The Vanguard Study: Testing a New Way to Screen for Cancer
招募中欢迎健康志愿者
- Walter Reed National Military Medical Center, Bethesda · 距离 7 英里
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy
招募中观察性研究
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
招募中3 期
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
招募中观察性研究
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Collection of Blood From Patients With Prostate Cancer
招募中观察性研究
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 距离 7 英里
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
招募中2 期
- MedStar Georgetown University Hospital, Washington D.C.
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Precision-Based Genomics in Prostate Cancer
招募中观察性研究
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Collection of Blood From Patients With Cancer
招募中观察性研究欢迎健康志愿者
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
招募中3 期
- MedStar Washington Hospital Center ( Site 0103), Washington D.C.
Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL
招募中观察性研究
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue
招募中观察性研究
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy
招募中2 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
招募中2 期
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor
招募中2 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
招募中3 期
- The GW Medical Faculty Associates ( Site 0057), Washington D.C.
- Washington DC Veterans Affairs Medical Center ( Site 0056), Washington D.C.
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
招募中3 期
- George Washington University Medical Center, Washington D.C.
- UM Capital Region Medical Center, Largo · 距离 11 英里
Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer
招募中观察性研究
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy
招募中2 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Men at High Genetic Risk for Prostate Cancer
招募中观察性研究
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer
招募中1/2 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer
招募中
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate Cancer
招募中2 期
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington D.C.
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
招募中3 期
- Sibley Memorial Hospital, Washington D.C.
- Suburban Hospital, Bethesda · 距离 7 英里
FOG-001 in Locally Advanced or Metastatic Solid Tumors
招募中1/2 期
- Johns Hopkins University, Sibley Memorial Hospital, Washington D.C.
Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer
招募中2 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
招募中3 期
- Sibley Memorial Hospital, Washington D.C.
- George Washington University Medical Center, Washington D.C.
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
招募中1 期
- Maryland Oncology Hematology, Silver Spring · 距离 7 英里
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
招募中观察性研究欢迎健康志愿者
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
招募中4 期
- VA Medical Center, Washington D.C.
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
招募中观察性研究欢迎健康志愿者
- Cancer Support Community Research & Training Institute, Washington D.C.
Clinical Trial of Approaches to Prostate Cancer Surgery
招募中
- Georgetown University, Washington D.C.
Castrate Resistant Prostate Cancer Enhertu Therapy
招募中2 期
- Washington DC VAMC, Washington D.C.
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
招募中2/3 期
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer
招募中欢迎健康志愿者
- Howard University Hospital, Washington D.C.
- National Cancer Institute, Bethesda · 距离 7 英里
- Walter Reed National Military Medical Center, Bethesda · 距离 7 英里
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Silver Spring · 距离 7 英里
- Massive Bio SYNERGY-AI site, Bethesda · 距离 7 英里
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
招募中3 期
- George Washington University Medical Center, Washington D.C.
其他城市的 前列腺癌试验
- New York City, NY103 项研究
- Houston, TX76 项研究
- Los Angeles, CA61 项研究
- Boston, MA59 项研究
- St. Louis, MO46 项研究
- Chicago, IL45 项研究
- San Francisco, CA45 项研究
- Philadelphia, PA44 项研究
- Baltimore, MD43 项研究
- Nashville, TN43 项研究
- Seattle, WA42 项研究
- Dallas, TX36 项研究
Washington的其他研究
- 癌症（所有类型）58 项研究
- 非小细胞肺癌55 项研究
- 乳腺癌46 项研究
- 转移性癌症43 项研究
- 肺癌41 项研究
- 肥胖症33 项研究
- 结直肠癌29 项研究
- 心血管疾病28 项研究
- 膀胱癌26 项研究
- 急性髓系白血病24 项研究
- 卵巢癌23 项研究
- 淋巴瘤23 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。